Ledger.Open graph →
SEC Form D · Amendment · filed February 7, 2019

Elucida Oncology, Inc

Offering
$30.0M
Sold
$28.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Robert A. Essner · New York, NYDirectorUlrich T. Wiesner · New York, NYDirectorGeno Germano · New York, NYExec · DirectorTeresa M. Ressel · New York, NYDirectorIsaac Blech · New York, NYDirectorRobert A. Ruffolo · New York, NYDirectorTim Boris · New York, NYDirectorMichael T. Smith · New York, NYDirectorVinay J. Patel · Granger, INDirectorJames J. Paglia · Lantana, TXDirectorAndy Weissman · New York, NYDirectorJohn J. Stimley · Michigan City, INDirectorSherree J. Tipton · Michigan City, INDirectorJason J. Stimley · LaPorte, INExec · DirectorEdward J. Graveline · Michigan City, INDirectorShaival Shah · New York, NYDirectorTomas Kiselak · Waltham, MADirectorKevin Butler · Grand Cayman, Cayman IslandsDirectorWarren Stoddart · Toronto, Ontario, CanadaExec · DirectorTrinda Blackmore · Grand Cayman, Cayman IslandsDirectorLivio Bisterzo · New York, NYDirectorHugh Thomas · New York, NYDirectorWilliam Gentile · NEW YORK, NYDirectorJohn Ajay · Boca Raton, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗